Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MM Incidence in Cardiothoracic Transplant Populace

JAMA Dermatology; ePub 2018 Feb 16; Puza, et al

Recent findings suggest that the cardiothoracic (heart and/or lung) transplant (CTT) population experiences an incidence of malignant melanoma (MM) similar to that of other solid organ transplant recipients and with a median of 2.5 years from transplant to melanoma diagnosis. This according to a retrospective cohort study of patients who underwent a CTT from 2001 through 2016 with a median follow-up time of 4.3 years. Researchers found:

  • 5 of 1,154 patients who underwent a CTT (0.4%) developed biopsy-proven MM at a median follow-up time of 4.3 years after transplantation at a median age of 64.5 years.
  • Of total patients, 923 (80%) were men.
  • Their mean (SD) age was 63.8 years (range, 27.2-68.2 years).
  • 4 patients (80%) presented with stage I disease while 1 (20%) presented with stage IV disease at a median time of 2.5 years after transplant compared with a median time of 6.2 years in a renal transplant population at a median follow-up time of 6.6 years.
  • 2 patients died after transplant, 1 owing to complications of the transplant and 1 owing to metastatic MM.
Citation:

Puza CJ, Cardones AR, Mosca PJ. Examining the incidence and presentation of melanoma in the cardiothoracic transplant population. [Published online ahead of print February 16, 2018]. JAMA Dermatology. doi:10.1001/jamadermatol.2018.0130.

This Week's Must Reads

Nevus Development Trajectory from Age 3 to 16 Years, JAMA Dermatology; ePub 2018 Sep 12; Asdigian, et al

Pruritis Strongly Associated with Certain Cancers , J Am Acad Dermatol; ePub 2018 Sep 11; Larson, et al

Trends in Medicare Billing Among Mohs Surgeons, Dermatolog Surg; ePub 2018 Sep 7; Tsai, et al

Mohs Surgery Effective for Invasive Melanomas, Dermatolog Surg; ePub 2018 Sep 7; Degesys, et al

Young Adults with Psoriasis Have Impaired QOL, J Dermatolog Treat; ePub 2018 Sep 7; Bronckers, et al

Must Reads in Melanoma

Nevus Development Trajectory from Age 3 to 16 Years, JAMA Dermatology; ePub 2018 Sep 12; Asdigian, et al

Mohs Surgery Effective for Invasive Melanomas, Dermatolog Surg; ePub 2018 Sep 7; Degesys, et al

Age, Sentinel Lymph Node Risk Link in Melanoma, J Am Acad Dermatol; ePub 2018 Aug 27; Hanna, et al

Recurrent Morphological Patterns in Melanomas, J Am Acad Dermatol; ePub Aug 27; Klebanov, et al

Sunless Tanning and Risky Cancer-related Behaviors, JAMA Dermatology; ePub 2018 Jul 25; Dodds, Arron, et al